8-32614527-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The ENST00000405005.8(NRG1):āc.414T>Cā(p.Gly138Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00125 in 1,612,674 control chromosomes in the GnomAD database, including 24 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0069 ( 13 hom., cov: 32)
Exomes š: 0.00065 ( 11 hom. )
Consequence
NRG1
ENST00000405005.8 synonymous
ENST00000405005.8 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0900
Genes affected
NRG1 (HGNC:7997): (neuregulin 1) The protein encoded by this gene is a membrane glycoprotein that mediates cell-cell signaling and plays a critical role in the growth and development of multiple organ systems. An extraordinary variety of different isoforms are produced from this gene through alternative promoter usage and splicing. These isoforms are expressed in a tissue-specific manner and differ significantly in their structure, and are classified as types I, II, III, IV, V and VI. Dysregulation of this gene has been linked to diseases such as cancer, schizophrenia, and bipolar disorder (BPD). [provided by RefSeq, Apr 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 8-32614527-T-C is Benign according to our data. Variant chr8-32614527-T-C is described in ClinVar as [Benign]. Clinvar id is 780750.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-32614527-T-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.09 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00694 (1056/152116) while in subpopulation AFR AF= 0.0237 (986/41538). AF 95% confidence interval is 0.0225. There are 13 homozygotes in gnomad4. There are 480 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1056 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NRG1 | NM_013964.5 | c.414T>C | p.Gly138Gly | synonymous_variant | 4/12 | ENST00000405005.8 | NP_039258.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NRG1 | ENST00000405005.8 | c.414T>C | p.Gly138Gly | synonymous_variant | 4/12 | 1 | NM_013964.5 | ENSP00000384620.2 |
Frequencies
GnomAD3 genomes AF: 0.00689 AC: 1047AN: 152000Hom.: 13 Cov.: 32
GnomAD3 genomes
AF:
AC:
1047
AN:
152000
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00180 AC: 451AN: 250724Hom.: 6 AF XY: 0.00131 AC XY: 177AN XY: 135460
GnomAD3 exomes
AF:
AC:
451
AN:
250724
Hom.:
AF XY:
AC XY:
177
AN XY:
135460
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000653 AC: 954AN: 1460558Hom.: 11 Cov.: 30 AF XY: 0.000586 AC XY: 426AN XY: 726534
GnomAD4 exome
AF:
AC:
954
AN:
1460558
Hom.:
Cov.:
30
AF XY:
AC XY:
426
AN XY:
726534
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00694 AC: 1056AN: 152116Hom.: 13 Cov.: 32 AF XY: 0.00645 AC XY: 480AN XY: 74380
GnomAD4 genome
AF:
AC:
1056
AN:
152116
Hom.:
Cov.:
32
AF XY:
AC XY:
480
AN XY:
74380
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
7
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
NRG1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 09, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at